NanoVibronix Announces Closing of $2.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesBusiness Wire • 12/01/22
NanoVibronix Announces $2.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesBusiness Wire • 11/29/22
NanoVibronix UroShield Approved for Sale through NHS Internal Supply Chain ContractBusiness Wire • 09/23/22
NanoVibronix Announces Distribution of Series F Preferred Stock to Holders of its Common StockBusiness Wire • 09/14/22
NanoVibronix Announces Receipt of Nasdaq Listing Determination; Company to Request HearingBusiness Wire • 09/02/22
NanoVibronix Strengthening Supply Chain Increasing Efficiency and ScalabilityBusiness Wire • 06/29/22
Top Penny Stocks Today: Why Are ADGI, DRCT, VYNT, NAOV, GERN and SNOA Rising Today?InvestorPlace • 03/30/22
NanoVibronix Announces PainGuard and UroGuard Approved by Health Canada as Licensed Medical DevicesBusiness Wire • 03/30/22